Philadelphia Suboxone Doctors

Join Here To Have Your Medical Practice Featured in this space

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

Philadelphia offers an extensive array of buprenorphine-approved doctors to help opiate dependent persons have relief from opioid withdrawal symptoms. Buprenorphine has been proven effective for a majority of individuals with a mild to moderate level of opiate addiction. While Suboxone (containing buprenorphine) was used in its early years of release for short-term opiate detox, suboxone is today appropriate for long term maintenance therapy much like methadone. If you are a local physician aiming to treat Philadelphia area residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



Philadelphia Buprenorphine Suboxone Doctors
Christopher Justin Pagnani, M.D. 1528 Walnut Street
Suite 2005
Philadelphia, PA 19102
(267) 687-2032
Donald John Kushon, M.D. Hahnemann Hospital
17306 Ncb, Ms 403
Philadelphia, PA 19102
(215) 762-1866
Richard M. Sobel, M.D. 1518 Walnut Street
Suite 1110
Philadelphia, PA 19102
(215) 731-1901
David M. Barclay III, M.D. 1601 Walnut Street
Suite 208
Philadelphia, PA 19102
(215) 988-9824
Michael D. Miller, M.D. 255 South 17th Street
Suite 1410
Philadelphia, PA 19103
(215) 545-8450
Michael J. McCarthy, M.D. 2400 Chestnut Street, Suite 1409
Philadelphia, PA 19103
(215) 567-4773
Henry Richard Kranzler, M.D. 3900 Chestnut Street
Philadelphia, PA 19104
(215) 222-3200
Anil K Rai, M.D. Veterans Affairs Medical Center Philadel
3900 Woodland Ave 7th Floor Psychiatry
Philadelphia, PA 19104
(215) 823-5800
Onuorah Umeh, M.D. 4237 Baltimore Avenue
Philadelphia, PA 19104
(724) 591-5236
Vasam P. Dhopesh, M.D. VA Medical Center
Suite 116A
Philadelphia, PA 19104
(215) 823-5800
Isabelle Arndt, M.D., Ph.D. Opiate Treatment Program, Bldg. # 7
38th & Woodland Avenue
Philadelphia, PA 19104
(215) 823-6092
John Listerud, M.D. Philadelphia VAMC, Seventh Floor
3900 Woodland Avenue
Philadelphia, PA 19104
(215) 823-4041
Kyle M. Kampman, M.D. Univ. of Penn, Treatment Research Ctr.
3900 Chestnut Street
Philadelphia, PA 19104
(215) 222-3200×109
Charles Dackis, M.D. University of Pennsylvania Medical Cntr
3900 Market Street
Philadelphia, PA 19104
(215) 662-8752
Michael Gliatto, M.D. Philadelphia Veterans Admin. Med Center
38th-Woodland Ave. 7thFloor MailStop116A
Philadelphia, PA 19104
(215) 823-4037
Steven Howard Snyderman, M.D. 51 North 39th Street
Suite W241
Philadelphia, PA 19104
(215) 662-8600
James W. Cornish, M.D. Department of Veterans Affairs Med Ctr.
3900 Woodland Avenue
Philadelphia, PA 19104-4594
(215) 823-5809
Charles P. O'Brien, M.D. UPENN, Philadelphia VAMC/MIRECC
3900 Chestnut Street
Philadelphia, PA 19104-6178
(215) 222-3200×132
Maurie Pressman, M.D. 200 Locust Street
Apartment 1705
Philadelphia, PA 19106
(215) 922-0204
George E. Woody, M.D. 150 South Independence Mall, West
Suite 600, Public Ledger Building
Philadelphia, PA 19106
(215) 399-0980×112
Nicole Andrea Matthews, D.O. 833 Chestnut Street
Suite 210
Philadelphia, PA 19107
(215) 416-7607
Richard A. Stefanic, M.D. Rossi Wellness Center
822 Pine Street, Suite LL1
Philadelphia, PA 19107
(267) 519-2174
Richard A. Stefanic, M.D. Rossi Wellness Center
822 Pine Street, Suite LL1
Philadelphia, PA 19107
(267) 519-2174
Sam Al-Saadi, M.D. 211 South Ninth Street
Suite 500
Philadelphia, PA 19107
(215) 955-4693
Ellen Davis Conroy, D.O. Jefferson Outpatient Psychiatry
833 Chestnut Street Suite 210
Philadelphia, PA 19107
(215) 955-8420
Angel S. Angelov, M.D. TJUH Dept. of Psychiatry
1652 Thompson Bldg, 1020 Sansom Street
Philadelphia, PA 19107
(215) 955-5308
Karam C Mounzer, M.D. 1233 Locust Street
Philadelphia, PA 19107
(215) 790-1788
John J. Bowden, Jr., D.O. 205 North Broad Street
Suite 500
Philadelphia, PA 19107
(215) 977-7844
Marna Sternbach, M.D. 833 Chestnut Street
Philadelphia, PA 19107
(215) 955-0429
Joseph M. Garland, M.D. 1233 Locust Street, Suite 500
Philadelphia, PA 19107
(215) 525-3047
Jessica Mosier, M.D. 833 Chestnut Street
Suite 210
Philadelphia, PA 19107
(215) 955-8420
Helen Carol Koenig, M.D. Philadelphia FIGHT
1233 Locust Street, 5th floor
Philadelphia, PA 19107
(215) 790-1788
William Christopher Jangro, M.D. 833 Chestnut Street
Suite 210
Philadelphia, PA 19107
(215) 955-6592
Basant Kumar Pradhan, M.D. 833 Chestnut Street
Suite 210
Philadelphia, PA 19107
(732) 742-3180
William Wright, Jr. 7246 Rising Sun Avenue
Philadelphia, PA 19111
(215) 745-7455
Heidi R. Vidal, M.D. 6239 Rising Sun Avenue
Philadelphia, PA 19111
(215) 543-5199
Neil L. Isdaner, M.D. 7602 Central Avenue
Stapley Building, Suite 103
Philadelphia, PA 19111
(215) 745-7411
Lawrence Robinson, M.D. Rising Sun Medical Center
7210 Rising Sun Avenue #B
Philadelphia, PA 19111-7157
(215) 613-7145
Brian Kenneth Stein, D.O. 3790 Morrell Avenue
Philadelphia, PA 19114
(215) 637-6901
Alan M. Burke, M.D. Dr. Alan Burke
1923 Welsh Road
Philadelphia, PA 19115
(800) 645-0721
Eugene Goldman, M.D. 9867 Bustleton Avenue
Philadelphia, PA 19115
(215) 698-9295
Andrew Mark Berkowitz, M.D. 9622 Bustleton Avenue
Suite 2B
Philadelphia, PA 19115
(215) 947-6143
Lilia Gorovits, M.D. 9867 Bustletoll Avenue
Philadelphia, PA 19115
(215) 698-9295
Stuart A. Kauffman, D.O. 1094 Welsh Road
Philadelphia, PA 19115
(215) 673-4100
Maurice Singer, D.O. 10663 Bustleton Avenue
Philadelphia, PA 19116
(215) 676-3336
 


Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone